Figures
Abstract
N-acetylneuraminate pyruvate lyase (NPL) catalyzes N-acetylneuraminic acid, the predominant sialic acid. Microarray analysis of the periimplantation mouse uterine luminal epithelium (LE) revealed Npl being the most downregulated (35×) gene in the LE upon embryo implantation. In natural pregnant mouse uterus, Npl expression increased 56× from gestation day 0.5 (D0.5) to D2.5. In ovariectomized mouse uterus, Npl was significantly upregulated by progesterone (P4) but downregulated by 17β-estradiol (E2). Progesterone receptor (PR) antagonist RU486 blocked the upregulation of Npl in both preimplantation uterus and P4-treated ovariectomized uterus. Npl was specifically localized in the preimplantation D2.5 and D3.5 uterine LE. Since LE is essential for establishing uterine receptivity, it was hypothesized that NPL might play a critical role in uterine function, especially during embryo implantation. This hypothesis was tested in the Npl(−/−) mice. No significant differences were observed in the numbers of implantation sites on D4.5, gestation periods, litter sizes, and postnatal offspring growth between wild type (WT) and Npl(−/−) females from mating with WT males. Npl(−/−)xNpl(−/−) crosses produced comparable little sizes as that from WTxWT crosses. Comparable mRNA expression levels of several genes involved in sialic acid metabolism were observed in D3.5 uterus and uterine LE between WT and Npl(−/−), indicating no compensatory upregulation in the D3.5 Npl(−/−) uterus and LE. This study demonstrates PR-mediated dynamic expression of Npl in the periimplantation uterus and dispensable role of Npl in uterine function and embryo development.
Citation: Xiao S, Li R, Diao H, Zhao F, Ye X (2013) Progesterone Receptor-Mediated Regulation of N-Acetylneuraminate Pyruvate Lyase (NPL) in Mouse Uterine Luminal Epithelium and Nonessential Role of NPL in Uterine Function. PLoS ONE 8(5): e65607. https://doi.org/10.1371/journal.pone.0065607
Editor: Ana Claudia Zenclussen, Medical Faculty, Otto-von-Guericke University Magdeburg, Medical Faculty, Germany
Received: April 4, 2013; Accepted: April 30, 2013; Published: May 31, 2013
Copyright: © 2013 Xiao et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Authors thank Dr. James N. Moore and Dr. Zhen Fu in the College of Veterinary Medicine, University of Georgia for access to the ABI 7900-Real-Time PCR machine and the imaging system, respectively; and the Graduate School, the Office of the Vice President for Research, Interdisciplinary Toxicology Program, and Department of Physiology & Pharmacology at University of Georgia, and National Institutes of Health (NIH R15HD066301 and NIH R01HD065939 to X.Y.) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: Co-author Xiaoqin Ye is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Introduction
N-acetylneuraminate pyruvate lyase (NPL), also named sialic acid aldolase or N-acetylneuraminate lyase, was originally purified and characterized in human related pathogenic as well as non-pathogenic bacteria that utilize the carbon sources in the mucus-rich surfaces of the human body, such as Clostridium perfringens and Escherichia coli [1]–[4]. The human NPL consists of 320 amino acids (33 kDa) and has a crystal structure of tetramer [5], [6]. Mammalian NPL proteins have 86 highly conserved amino acids, which are slightly different from the bacterial counterpart [6]. A splice variant of human NPL is highly expressed in human liver, kidney, ovary, and peripheral blood leukocyte [7].
NPL catalyzes the breaking of carbon-carbon bonds of N-acetylneuraminic acid, the predominant sialic acid, into N-acetylmannosamine and pyruvate, thus regulating the cellular concentrations of sialic acid and preventing the recycling of sialic acid for further sialiation with glycoconjuates in the Golgi compartment [8], [9]. In both bacteria and mammalians, sialic acids such as N-acetylneuraminic acid (Neu5Ac) and N-glycolylneur aminic acid (Neu5Gc) are involved in the sialylation and provide the diversity of sialylated oligosaccharides [10]–[12]. Sialic acids have been associated with intercellular adhesion, protein recognition, and immune-related mechanisms [13], [14].
Limited reports suggest that NPL may have functions in female reproduction but the potential role of NPL in female reproduction has not been previously investigated. For example, serum sialic acid level increases with the progression of pregnancy compared with that in non-pregnant women [15]–[17]; uterine sialic acid concentration decreases upon ovariectomy in Indian langur monkeys, but increases upon ovarian hormones E2 or E2+P4 treatments [18]. NPL came to our attention from our microarray analysis of mouse periimplantation uterine luminal epithelium (LE) (GEO number: GSE44451). Npl was the most downregulated (35×) gene in the postimplantation gestation day 4.5 (D4.5) LE compared with that in the preimplantation D3.5 LE (Xiao et al, submitted). Further analysis indicated peak expression of Npl in the preimplantation D2.5 and D3.5 uterine LE. Since LE is critical for the receptive sensitivity of the uterus [19], [20], we hypothesized that NPL might be involved in uterine function, especially uterine preparation for embryo implantation. This hypothesis was tested in Npl(−/−) mice.
Materials and Methods
Animals and genotyping
Npl(−/−) mice were generated from the mouse strain B6/129S5-NplGt(IRESBetageo)332Lex/Mmucd (identification number 011743-UCD) and purchased from the Mutant Mouse Regional Resource Center (MMRRC) at UC Davis, a NCRR-NIH funded strain repository. Npl(−/−) mice were genotyped using tail genomic DNA and three primers in PCR reactions: Primer 0920-5′: GGCATATATGTGCAGGCAGAATGC, Primer LTR-rev: ATAAACCCTCTTGCAGTTGCATC, and Primer 0920-3′: TCTAGAAATGAGTCTGAACCGGAC. The genotyping PCR cycles were: 10 cycles of 94°C for 15s, 65°C for 30 s (decreased 1°C/cycle), 72°C for 40 s; and 30 cycles of 94°C for 15 s, 55°C for 30 s and 72°C for 40 s. The expected PCR product sizes for wild type (WT) (Primer 0920-5′ and Primer 0920-3′) and Npl(−/−) (Primer 0920-5′ and Primer LTR-rev) were 115 bp and 163 bp, respectively. All mice were housed in polypropylene cages with free access to regular food and water from water sip tubes in a reverse osmosis system. The animal facility is on a 12-hour light/dark cycle (7:00 AM to 7:00 PM) at 23±1°C with 30–50% relative humidity. All methods used in this study were approved by the University of Georgia Institutional Animal Care and Use Committee (IACUC) and conform to the National Institutes of Health guidelines and public law. All the animal studies were summarized in Table 1.
Mating and uterine tissue collection
Young virgin females were mated naturally with WT stud males and checked for a vaginal plug the next morning. The day a vaginal plug identified was designated as gestation day 0.5 (D0.5, mating night as D0). Uterine tissues were collected from euthanized females between 11:00 h and 12:00 h on D0.5, D1.5, D2.5, D3.5, D4.5, D5.5, and D7.5, respectively. Uterine horns from D0.5 to D2.5 females were quickly removed and snap-frozen on dry ice. Oviducts from these mice were flushed with 1×PBS for the presence of eggs or fertilized embryos to determine the pregnancy status. About 1/3 of a uterine horn from each euthanized D3.5 female was frozen on dry ice for tissue sectioning. The remaining D3.5 uterine horns were flushed with 1×PBS (to determine the status of pregnancy and to remove the influence of embryos on uterine gene expression) and frozen on dry ice for RNA isolation. On D4.5, D5.5, or D7.5, mice were anesthetized with isoflurane by inhalation and intravenously (i.v.) injected with Evans blue dye to visualize the implantation sites as previously described [21]. At least three pregnant mice were included in each group.
Hormonal treatment
Progesterone (P4), 17β-estradiol (E2), ICI 182780 (ER antagonist), or RU486 (PR antagonist) treatments on ovariectomized WT mice or early pregnant WT mice were done as previously reported [22]–[24]. Briefly, the ovariectomized 6 weeks old virgin WT females (recovered for 2 weeks after surgery) were s.c. injected with 0.1 ml sesame oil (vehicle group) or 0.1 ml 20 mg/ml P4 three times on 0 h, 24 h and 48 h, respectively. In the E2-treated group, the ovariectomized mice were injected with 0.1 ml oil on 0 h and 24 h, then 0.1 ml 1 µg/ml E2 on 48 h. In the P4+E2 -treated group, the ovariectomized mice were treated the same as the P4 treated group except an additional injection of 0.1 ml 1 µg/ml E2 on 48 h. All injected mice were dissected 6 hours after the last injection. The total treatment time of P4 and E2 were 54 hours and 6 hours, respectively. Another set of ovariectomized mice were treated with 0.1 ml sesame oil (vehicle group), 0.1 ml 20 mg/ml P4, 0.1 ml 20 mg/ml P4 and 200 µg/ml RU486 (P4+RU486 group), or 0.1 ml 200 µg/ml RU486 (RU486 group), respectively. All mice were dissected 24 hours post injection and the uterine tissues were snap-frozen on dry ice. The third set of treatments was on naturally mated early pregnant mice. They were treated with 0.1 ml sesame oil (vehicle group), 0.1 ml 200 µg/ml ICI 182780 (ICI 182780 group), or 0.1 ml 200 µg/ml RU486 (RU486 group) on D2.5, and dissected on D3.5. The pregnancy status was determined as mentioned above. About 1/3 of a uterine horn from each female was snap-frozen for in situ hybridization. The remaining uterine horns were flushed with 1×PBS and snap-frozen for realtime PCR.
LE isolation
D3.5 uteri from naturally mated WT and Npl(−/−) mice were processed for LE isolation as previously described using 0.5% dispase enzyme and gentle scraping [22]. The pregnancy status was determined by the presence of blastocyst(s). At least five pregnant mice were included in each group.
Realtime PCR
Total RNA from whole uterine horns or LE sheets were isolated using TRIzol. cDNA was reverse-transcribed from one microgram of total RNA using Superscript III reverse transcriptase with random primers (Invitrogen, Carlsbad, CA, USA). Realtime PCR was performed in 384-well plates using Sybr-Green I intercalating dye on ABI 7900 (Applied Biosystems, Carlsbad, CA, USA) to quantify the mRNA expression levels of Npl and several other sialic acid metabolism related genes, including glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (Gne), N-acetylneuraminic acid synthase (Nans), N-acetylneuraminic acid phosphatase (Nanp), cytidine monophosphate N-acetylneuraminic acid synthetase (Cmas), cytidine monophospho-N-acetylneuraminic acid hydroxylase (Cmah), solute carrier family 35, member A1 (Slc35a1), sialidase 1 (Neu1), sialidase 3 (Neu3), solute carrier family 17, member 5 (Slc17a5), ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (St3gal1),), ST3 beta-galactoside alpha-2,3-sialyltransferase 4 (St3gal4), ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 (St8sia5). The mRNA expression levels were normalized by the expression of Gadph (glyceraldehyde-3-phosphate dehydrogenase). Hprt1 (hypoxanthine phosphoribosyltransferase 1) served as the second house-keeping gene. Primer sequences (Integrated DNA Technology, San Diego, CA, USA) were shown in Table 2.
In situ hybridization
In situ hybridization was performed as previously described [22], [25], [26]. Sense and antisense probes for Npl, proline-rich acidic protein 1 (Prap1), amiloride binding protein 1 (Abp1), decidual/trophoblast prolactin-related protein (Dtprp) were synthesized from a cDNA fragment amplified with their respective gene specific primer pairs (Table 2).
Postnatal growth, embryo implantation, gestation period, and litter size
The postnatal body weights of WT, Npl(+/−), and Npl(−/−) pups were recorded weekly. Young virgin WT, Npl(+/−), and Npl(−/−) females (2–4 months old) were mated with WT stud males to determine the effect of Npl-deficiency on female reproduction. The numbers of implantation sites were recorded on D4.5. Gestation periods and litter sizes were recorded as previously described [21]. Another set of Npl(+/−) and Npl(−/−) females were mated with Npl(−/−) males to determine the effect of Npl-deficiency on embryo development. WT and Npl(−/−) females were mated with Npl(−/−) males to determine the fertility of Npl(−/−) males.
Access to online data about NplGt(OST15553)Lex
Detail information from the original producer of Npl(−/−) mice about fertility, blood chemistry, cardiology, immunology and neurology, etc. of Npl(−/−) mice is available on the following link: http://www.informatics.jax.org/external/ko/lexicon/2492.html.
Results and Discussion
Differential expression of Npl in periimplantation mouse uterus
To determine the spatiotemporal uterine expression of Npl during early pregnancy, the mRNA expression of Npl was examined in the periimplantation uterus by realtime PCR and in situ hybridization. Realtime PCR indicated that Npl was expressed at a very low level in the D0.5 uterus; it was increased 4× in the D1.5 uterus and 56× in the D2.5 uterus; its expression level was slightly lower (44×) in the D3.5 uterus compared to that in the D2.5 uterus; upon embryo implantation, Npl expression level in the D4.5 uterus returned to a level comparable to that of D1.5 uterus (Fig. 1A). In situ hybridization didn't detect any significant Npl signal in the D0.5 and D1.5 uterus (Figs. 1B, 1C). Npl was exclusively detected in the uterine luminal epithelium (LE) on D2.5 and D3.5 with comparable intensity (Figs. 1D, 1E) but undetectable in the postimplantation uterus from D4.5 to D7.5 (Fig. 1F and data not shown). One study indicated that Npl expression is >5× lower in the LE at the implantation site than that in the LE of inter-implantation site on D4.5 [27]. However, in situ hybridization on longitudinal sections of D4.5 uterus did not detect any Npl signal in the inter-implantation site (data not shown). It suggests that the Npl expression levels in the D4.5 LE from implantation site and inter-implantation site are too low to be detected by in situ hybridization, similar as that in the D0.5 and D1.5 uterus (Fig. 1A). The upregulation of Npl in the preimplantation LE was consistent with microarray (GEO number: GSE44451) and realtime PCR results (Fig. 1A).
A. Expression of Npl in the periimplantation wild type (WT) uterus using realtime PCR. N = 4–6. * p<0.05, compared to gestation day 0.5 (D0.5); # p<0.05, compared to D1.5 and D4.5. Gapdh (glyceraldehyde 3-phosphate dehydrogenase), a house keeping gene as a loading control; error bars, standard deviation. B–G. Localization of Npl in the periimplantation uterus by in situ hybridization using Npl antisense probe. B. D0.5 WT (+/+) uterus. C. D1.5 WT uterus. D. D2.5 WT uterus. E. D3.5 WT uterus. F. D4.5 WT uterus. G. D3.5 Npl(−/−) uterus. Red star, embryo; LE, luminal epithelium; S, stroma; D, decidual zone; scale bar, 50 µm. N = 2–3.
PR-mediated upregulation of Npl in preimplantation mouse uterus
Uterine gene expression is largely controlled by ovarian hormones P4 and E2, whose functions are mediated via their receptors PR and ER, respectively [28], [29]. To determine the molecular mechanism for Npl upregulation in the preimplantation uterus, D2.5 WT females were treated with PR antagonist RU486 or ER antagonist ICI 182780 and Npl expression level was analyzed in the D3.5 uterus by realtime PCR. No significant difference in Npl expression was observed between ICI 182780-treated and vehicle-treated groups (Fig. 2A). However, dramatically reduced Npl expression was observed in the RU486-treated group (53× compared to vehicle-treated control) (Fig. 2A). The expression of the house-keeping gene Hprt1 was not changed upon ICI 182780 or RU486 treatments (Fig. 2A). These results indicated that PR mediated the upregulation of Npl in the preimplantation uterus.
A. Expression of Npl in the preimplantation uterus treated with estrogen receptor antagonist ICI 182780 or progesterone receptor antagonist RU486 (N = 3–4). B. Regulation of Npl by progesterone (P4) and 17β-estradiol (E2) in ovariectomized uterus (N = 4–6). * p<0.05, compared to oil-treated group. C. Effect of RU486 on P4 induced uterine Npl expression in ovariectomized mice (N = 4–5). * p<0.05, compared to oil-treated group; # p<0.05, compared to P4 treated group; Gapdh (glyceraldehyde 3-phosphate dehydrogenase), a house keeping gene as a loading control; Hprt1 (hypoxanthine phosphoribosyltransferase 1), another house keeping gene; error bars, standard deviation.
Hormonal regulation of Npl in ovariectomized mouse uterus
In ovariectomized WT mice, Npl was significantly upregulated (45×) by P4 treatment and downregulated (6×) by E2 treatment in the uterus (Fig. 2B). P4-induced Npl upregulation was greatly reduced by co-administration of E2, although the expression level of Npl was still 3-fold higher than that in the vehicle-treated uterus (Fig. 2B). In situ hybridization revealed that P4-induced upregulation of Npl was also detected in the LE of the ovariectomized uterus (data not shown), similar as that in the preimplantation uterus (Figs. 1D, 1E). To determine the involvement of PR in the regulation of Npl in the ovariectomized uterus, another set of experiment was performed. The results indicated that P4-induced upregulation of Npl in the ovariectomized uterus was completely abolished by co-administration of RU486, whereas RU486 alone did not seem to affect Npl expression (Fig. 2C). The expression of the house-keeping gene Hprt1 was not changed upon different hormonal treatments (Fig. 2). These data demonstrated that P4-PR signaling mediated the upregulation of Npl in the mouse uterus.
The coordinated uterine regulation of Npl by both P4 and E2 could explain the temporal expression of Npl in the early pregnant uterus (Fig. 1A). After D1.5, P4 secretion from the newly formed corpus luteum increases [30] and correspondingly, Npl expression levels increase in the D2.5 and D3.5 uterus (Fig. 1). On D3.5, superimposed ovarian estrogen secretion, which makes the P4-primed uterus receptive for embryo implantation [30], [31], may contribute to the downregulation of Npl (Figs. 1A, 1F, 2B). However, since ER antagonist ICI 182780 does not significantly affect the expression of Npl in the preimplantation uterus and PR antagonist RU486 dramatically suppresses the expression of Npl in the preimplantation uterus (Fig. 2A), it is more likely that the downregulation of Npl in the postimplantation LE (Fig. 1F) is the consequence of the downregulation of PR in the postimplantation LE [26].
Since NPL catalyzes the dominant sialic acid N-acetylneuraminic acid, it is expected that its downregulation could lead to elevated sialic acid in the uterus. The downregulation of Npl expression upon E2 treatment in the ovariectomized mouse uterus (Fig. 2B) seems to agree with the increased uterine sialic acid concentration upon E2 treatment in the ovariectomized Indian langur monkeys [18].
LE is the first cellular layer that an implanting embryo communicates with for implantation. Considering the observations that Npl is the most dramatically differentially expressed gene in the periimplantation LE (Fig. 1) (Xiao S et al, submitted) and Npl is upregulated in the preimplantation uterus via P4-PR signaling (Fig. 2), we hypothesized that Npl might play a role in uterine function, especially uterine preparation for embryo implantation. This hypothesis was tested in the Npl(−/−) mice and appeared to be supported by the preliminary fertility data on MMRRC website, which indicated that the average litter size from Npl(−/−) females (mated with WT males) was 1.67±1.53 (N = 3), significantly smaller than that from WT females (mated with Npl(−/−) males) with an average litter size of 7.67±2.08 (N = 3, P<0.05) (http://www.informatics.jax.org/external/ko/lexicon/2492.html).
General characterization of Npl(−/−) mice
Deletion of Npl was confirmed by genotyping and lack of Npl signal in both D2.5 and D3.5 Npl(−/−) uteri by in situ hybridization (Fig. 1G and data not shown). There was no significant difference in postnatal growth among WT, Npl(+/−), and Npl(−/−) mice of the same genders (data not shown). The percentages of WT, Npl(+/−), and Npl(−/−) offspring from 27 litters (224 pups at weaning) of Npl(+/−) and Npl(+/−) crosses were 24.55%, 54.91%, and 20.54%, respectively. Among them, 117 (52.23%) were females and 107 (47.77%) were males. No obvious difference in mating activities was observed between WT and Npl(−/−) mice in both genders.
Normal embryo implantation and postimplantation pregnancy in Npl(−/−) females
Embryo implantation initiates around D4.0 in mice [26]. On D4.5, all the pregnant Npl(−/−) females had implantation sites detected by blue dye injection as seen in the WT females (Figs. 3A, 3B). The intensity and spacing of the blue bands, which indicated the implantation sites, and the average numbers of implantation sites between WT and Npl(−/−) females were comparable (Figs. 3A–3C). These data indicated no obvious defect in embryo implantation, which was confirmed by the comparable uterine expression of Prap1 and Abp1 (Figs. 4D–4G), a uterine LE marker [25] and a decidualization marker [32] upon embryo implantation, respectively. These results also indicated that all the preimplantation events, including oogenesis, ovulation, fertilization, embryo transport, and preimplantation embryo development, were not impaired. Postimplantation decidualization was also well developed in the D5.5 and D7.5 Npl(−/−) uteri, demonstrated by the comparable expression of a decidualization marker Dtprp [33] in D5.5 and D7.5 WT and Npl(−/−) uterus (Figs. 3H–3K). In fact, no obvious defect was detected in the Npl(−/−) females during the entire pregnancy, revealed by the comparable gestation periods, litter sizes, survival rates, and postnatal growth of offspring from females with different genotypes when they were mated with WT males (Figs. 4A, 4B, and data not shown). These results proved our hypothesis wrong and didn't support the preliminary fertility data reported in the MMRRC website (http://www.informatics.jax.org/external/ko/lexicon/2492.html).
+/+, wild type (WT); −/−, Npl(−/−). A. A representative uterus from D4.5 WT mice. B. A representative uterus from D4.5 Npl(−/−) mice. Red arrow, implantation site. C. the number of implantation sites on D4.5. N, the number of female mice in each group; error bars, standard deviation. D–G. Expression of implantation markers in D4.5 uterus by in situ hybridization using Prap1 and Abp1 antisense probes, respectively. D. Prap1 in WT uterus. E. Prap1 in Npl(−/−) uterus. F. Abp1 in WT uterus. G. Abp1 in Npl(−/−) uterus. H–K. Expression of decidualization marker, Dtprp, in D5.5 and D7.5 uterus by in situ hybridization using Dtprp antisense probes. H. Dtprp in D5.5 WT uterus. I. Dtprp in D5.5 Npl(−/−) uterus. J. Dtprp in D7.5 WT uterus. K. Dtprp in D7.5 Npl(−/−) uterus. Red star, embryo; LE, luminal epithelium; D, decidual zone; scale bar, 100 µm (D–G) and 500 µm (H–K). N = 2–3. No signals were detected using Prap1, Abp1, or Dtprp sense probes (data not shown).
+/+, wild type; +/−, Npl(+/−); −/−, Npl(−/−); F, female; M, male; N, the number of female mice in each group; error bars, standard deviation.
Non-essential role of Npl in male fertility and embryo development
The WT and Npl(−/−) males had comparable testis weight, sperm counts from cauda epididymis, and litter sizes when they were mated with WT females (data not shown), indicating normal fertility of Npl(−/−) males.
When Npl(+/−) or Npl(−/−) females were mated with Npl(−/−) males, they produced comparable litter sizes to that from WTxWT crosses (Fig. 4B). These data demonstrated that deletion of Npl did not have an obviously adverse effect on embryo development.
No compensatory mRNA expression of other genes involved sialic acid metabolism in D3.5 Npl(−/−) uterus
The following genes are known to play roles in sialic acid metabolism: Gne, Nans, and Nanp, which are important for the sialic acid synthesis from the UDP-N-acetylglucosamine (UDP-GlcNAc) to Neu5Ac in cytosol; Cmas and Cmah, which catalyze Neu5AC to CMP-Neu5Ac and then Neu5Gc; Slc35a1, which transports CMP-Neu5Ac and CMP-Neu5Gc to Golgi compartment for further glycosylation; St3gal1 and St3gal4, which are sialytransferases controlling the glycosylation of sialic acid with carbohydrates, glycoproteins, and glycolipids; Neu1 and Neu3, which are neuraminidases responsible for the removal of sialic acid residues from glycoconjugates in different intracellular compartments, such as lysosome, plasma membrane, and mitochondria; Slc17a5, which transports free sialic acid back to the cytosol; and Npl, which degrades the free sialic acid to N-acetylmannosamine and pyruvate in the cytosol [7], [34].
Since Npl expression peaks in the preimplantation uterine LE (Fig. 1), the mRNA expression levels of the above mentioned genes involved in sialic acid metabolism were examined in the preimplantation D3.5 WT and Npl(−/−) uteri by realtime RT-PCR. The results showed comparable mRNA expression levels of all these genes between WT and Npl(−/−) uteri (Fig. 5A). Since Npl is an LE-specific gene (Fig. 1) and LE comprises <10% of the uterine cells [19], [20], [35], any compensatory mRNA changes of these genes in the LE could potentially be covered in the whole uterine gene expression analysis. Therefore, LE cells from D3.5 WT and Npl(−/−) uteri were isolated for determining the mRNA expression of these genes. Realtime RT-PCR still failed to detect any significant difference of these genes between D3.5 WT and Npl(−/−) LE (Fig. 5B). Npl was included in both uterine and LE analyses (Figs. 5A, 5B) to indicate the deletion of Npl in the Npl(−/−) uterus. Based on the relative expression levels compared to the house-keeping gene Gapdh, Npl was enriched in the LE (Fig. 5), consistent with the in situ data (Fig. 1E). These results indicated no compensatory mRNA expression of these genes involved in sialic acid metabolism in the D3.5 Npl(−/−) whole uterus (Fig. 5A) and LE (Fig. 5B).
+/+, wild-type; −/−, Npl(−/−); X-axis indicated the names of the examined genes. Y-axis showed the normalized mRNA expression levels by Gapdh (glyceraldehyde 3-phosphate dehydrogenase) x103. Hprt1 (hypoxanthine phosphoribosyltransferase 1) served as the second house-keeping gene. N = 5–6. Error bars, standard deviation.
It has been reported that disruption of sialic acid metabolism and transport could have adverse effects. In mice, inactivation of Gne, which is important for sialic acid synthesis in the cytosol, leads to early postnatal lethality [36]. In humans, mutations of Slc17a5, which transports the free sialic acid from lysosome to cytosol for further degradation, could lead to the sialic acid storage disease (SASD) caused by sialic acid accumulation in the lysosome, and developmental delays and growth retardation [37]. In bacterial species, mutations of Npl, which degrades sialic acid in the cytosol, could lead to toxic overexpression of sialic acid [38]. These results indicate that balanced sialic acid metabolism and compartmentalization are critical for normal physiological functions.
Normal embryo implantation in the Npl(−/−) females (Fig. 3) indicates that NPL is not essential for embryo implantation. However, being the most downregulated gene in the postimplantation LE implies that it might have redundant, although nonessential, roles in uterine preparation for embryo implantation. Our unpublished microarray data demonstrated that Npl expression was significantly decreased in the pregnant mouse uterus compared to that in the pseudopregnant mouse uterus at 22:00 h on D3.5 (data not shown), right before embryo attachment to the LE for implantation indicated by blue dye reaction [26], suggesting that downregulation of Npl might contribute to the initiation of embryo attachment. Since NPL degrades sialic acid that is involved in cell adhesion [39], it is possible that downregulation of Npl could potentially facilitate embryo attachment to the LE for embryo implantation. On the other hand, sialic acid can block the access of antigenic molecules to the cell surface [40] while NPL from C. perfringens can dramatically increase (25×) the capacity of B cell antigen presentation [41]. It is possible that NPL might be involved in modulating the uterine immune response during early stages of embryo implantation [42].
In summary, this study demonstrates PR-mediated spatiotemporal expression of Npl in the periimplantation mouse uterus and the nonessential role of Npl in uterine function and embryo development.
Acknowledgments
Authors thank Dr. James N. Moore and Dr. Zhen Fu in the College of Veterinary Medicine, University of Georgia for access to the ABI 7900-Real-Time PCR machine and the imaging system, respectively; and the Graduate School, the Office of the Vice President for Research, Interdisciplinary Toxicology Program, and Department of Physiology & Pharmacology at University of Georgia, and National Institutes of Health for financial support.
Author Contributions
Conceived and designed the experiments: SX HD XY. Performed the experiments: SX RL HD FZ XY. Analyzed the data: SX HD XY. Wrote the paper: SX XY.
References
- 1. Aisaka K, Igarashi A, Yamaguchi K, Uwajima T (1991) Purification, crystallization and characterization of N-acetylneuraminate lyase from Escherichia coli. Biochem J 276 Pt2 541–546.
- 2. Aisaka K, Uwajima T (1986) Cloning and constitutive expression of the N-acetylneuraminate lyase gene of Escherichia coli. Appl Environ Microbiol 51: 562–565.
- 3. Ohta Y, Shimosaka M, Murata K, Tsukada Y, Kimura A (1986) Molecular-Cloning of the N-Acetylneuraminate Lyase Gene in Escherichia-Coli K-12. Applied Microbiology and Biotechnology 24: 386–391.
- 4. Meysick KC, Dimock K, Garber GE (1996) Molecular characterization and expression of a N-acetylneuraminate lyase gene from Trichomonas vaginalis. Mol Biochem Parasitol 76: 289–292.
- 5. Sommer U, Traving C, Schauer R (1999) The sialate pyruvate-lyase from pig kidney: purification, properties and genetic relationship. Glycoconj J 16: 425–435.
- 6. Schauer R, Sommer U, Kruger D, van Unen H, Traving C (1999) The terminal enzymes of sialic acid metabolism: acylneuraminate pyruvate-lyases. Biosci Rep 19: 373–383.
- 7. Wu M, Gu S, Xu J, Zou X, Zheng H, et al. (2005) A novel splice variant of human gene NPL, mainly expressed in human liver, kidney and peripheral blood leukocyte. DNA Seq 16: 137–142.
- 8. Vimr ER, Troy FA (1985) Regulation of sialic acid metabolism in Escherichia coli: role of N-acylneuraminate pyruvate-lyase. J Bacteriol 164: 854–860.
- 9. Schauer R (1982) Chemistry, metabolism, and biological functions of sialic acids. Adv Carbohydr Chem Biochem 40: 131–234.
- 10. Severi E, Hood DW, Thomas GH (2007) Sialic acid utilization by bacterial pathogens. Microbiology 153: 2817–2822.
- 11. Vimr ER, Kalivoda KA, Deszo EL, Steenbergen SM (2004) Diversity of microbial sialic acid metabolism. Microbiol Mol Biol Rev 68: 132–153.
- 12. Wang B (2012) Molecular mechanism underlying sialic acid as an essential nutrient for brain development and cognition. Adv Nutr 3: 465S–472S.
- 13. Varki A (2007) Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature 446: 1023–1029.
- 14. Traving C, Schauer R (1998) Structure, function and metabolism of sialic acids. Cell Mol Life Sci 54: 1330–1349.
- 15. Crook M, Constable S, Lumb P, Rymer J (1997) Elevated serum sialic acid in pregnancy. J Clin Pathol 50: 494–495.
- 16. Rajan R, Sheth AR, Rao SS (1983) Sialic acid, sialyltransferase and neuraminidase levels in maternal plasma, urine and lymphocytes during pregnancy and post-partum period–a longitudinal study in women. Eur J Obstet Gynecol Reprod Biol 16: 37–46.
- 17. Alvi MH, Amer NA, Sumerin I (1988) Serum 5-nucleotidase and serum sialic acid in pregnancy. Obstet Gynecol 72: 171–174.
- 18. Shandilya LN, Ramaswami LS, Shandilya N (1977) Sialic acid concentration in the reproductive organs, pituitary gland and urine of the Indian langur monkey (Presbytis entellus entellus). J Endocrinol 73: 207–213.
- 19. Denker HW (1993) Implantation: a cell biological paradox. J Exp Zool 266: 541–558.
- 20. Cowell TP (1969) Implantation and development of mouse eggs transferred to the uteri of non-progestational mice. J Reprod Fertil 19: 239–245.
- 21. Ye X, Hama K, Contos JJ, Anliker B, Inoue A, et al. (2005) LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 435: 104–108.
- 22. Ye X, Herr DR, Diao H, Rivera R, Chun J (2011) Unique uterine localization and regulation may differentiate LPA3 from other lysophospholipid receptors for its role in embryo implantation. Fertil Steril 95: 2107–2113 e2104.
- 23. Brown N, Deb K, Paria BC, Das SK, Reese J (2004) Embryo-uterine interactions via the neuregulin family of growth factors during implantation in the mouse. Biol Reprod 71: 2003–2011.
- 24. Diao H, Xiao S, Cui J, Chun J, Xu Y, et al. (2010) Progesterone receptor-mediated up-regulation of transthyretin in preimplantation mouse uterus. Fertil Steril 93: 2750–2753.
- 25. Diao H, Xiao S, Zhao F, Ye X (2010) Uterine luminal epithelium-specific proline-rich acidic protein 1 (PRAP1) as a marker for successful embryo implantation. Fertil Steril 94: 2808–2811 e2801.
- 26. Diao H, Paria BC, Xiao S, Ye X (2011) Temporal expression pattern of progesterone receptor in the uterine luminal epithelium suggests its requirement during early events of implantation. Fertil Steril 95: 2087–2093.
- 27. Chen Y, Ni H, Ma XH, Hu SJ, Luan LM, et al. (2006) Global analysis of differential luminal epithelial gene expression at mouse implantation sites. J Mol Endocrinol 37: 147–161.
- 28. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, et al. (1995) Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9: 2266–2278.
- 29. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, et al. (1993) Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A 90: 11162–11166.
- 30. Wang H, Dey SK (2006) Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet 7: 185–199.
- 31. Ma WG, Song H, Das SK, Paria BC, Dey SK (2003) Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation. Proceedings of the National Academy of Sciences of the United States of America 100: 2963–2968.
- 32. Liang X, Zhao Z, Deng W, Tian Z, Lei W, et al. (2010) Estrogen regulates amiloride-binding protein 1 through CCAAT/enhancer-binding protein-beta in mouse uterus during embryo implantation and decidualization. Endocrinology 151: 5007–5016.
- 33. Bany BM, Cross JC (2006) Post-implantation mouse conceptuses produce paracrine signals that regulate the uterine endometrium undergoing decidualization. Dev Biol 294: 445–456.
- 34. Wickramasinghe S, Medrano JF (2011) Primer on genes encoding enzymes in sialic acid metabolism in mammals. Biochimie 93: 1641–1646.
- 35. Carlino C, Stabile H, Morrone S, Bulla R, Soriani A, et al. (2008) Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy. Blood 111: 3108–3115.
- 36. Galeano B, Klootwijk R, Manoli I, Sun M, Ciccone C, et al. (2007) Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. J Clin Invest 117: 1585–1594.
- 37. Kleta R, Aughton DJ, Rivkin MJ, Huizing M, Strovel E, et al. (2003) Biochemical and molecular analyses of infantile free sialic acid storage disease in North American children. Am J Med Genet A 120A: 28–33.
- 38. Vimr ER, Troy FA (1985) Identification of an inducible catabolic system for sialic acids (nan) in Escherichia coli. J Bacteriol 164: 845–853.
- 39. Kelm S, Schauer R, Manuguerra JC, Gross HJ, Crocker PR (1994) Modifications of cell surface sialic acids modulate cell adhesion mediated by sialoadhesin and CD22. Glycoconj J 11: 576–585.
- 40. Bagriacik EU, Miller KS (1999) Cell surface sialic acid and the regulation of immune cell interactions: the neuraminidase effect reconsidered. Glycobiology 9: 267–275.
- 41. Frohman M, Cowing C (1985) Presentation of antigen by B cells: functional dependence on radiation dose, interleukins, cellular activation, and differential glycosylation. J Immunol 134: 2269–2275.
- 42. Yoshinaga K (2012) Two concepts on the immunological aspect of blastocyst implantation. J Reprod Dev 58: 196–203.